Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Lemonade
LMND
$3.74B
| $933K | ﹤0.01% |
80,303
-23,847
| -23% | -$383K |
|
2502
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.92B
| $932K | ﹤0.01% |
16,308
+2,179
| +15% | +$131K |
|
2503
PUT
Vertiv
VRT
$93B
| $930K | ﹤0.01% |
+25,000
| New | +$824K |
|
2504
PUT
Moderna
MRNA
$21.8B
| $930K | ﹤0.01% |
9,000
| – | – |
|
2505
Ingevity
NGVT
$2.51B
| $929K | ﹤0.01% |
19,507
-8,821
| -31% | -$482K |
|
2506
CareDx
CDNA
$2.26B
| $928K | ﹤0.01% |
132,560
+8,768
| +7% | +$81K |
|
2507
iShares MSCI Singapore ETF
EWS
$1.04B
| $926K | ﹤0.01% |
50,437
-1,456
| -3% | -$27.3K |
|
2508
Harley-Davidson
HOG
$2.58B
| $924K | ﹤0.01% |
27,957
+5,673
| +25% | +$197K |
|
2509
Trustmark
TRMK
$2.76B
| $924K | ﹤0.01% |
42,502
-36,866
| -46% | -$856K |
|
2510
Enlight Renewable Energy
ENLT
$11.8B
| $920K | ﹤0.01% |
58,811
-10,185
| -15% | -$177K |
|
2511
Nexstar Media Group
NXST
$5.82B
| $919K | ﹤0.01% |
6,409
-4,198
| -40% | -$681K |
|
|
LIAN
2512
DELISTED
LianBio American Depositary Shares
LIAN
| $918K | ﹤0.01% |
615,940
-91,396
| -13% | -$174K |
|
2513
Jack in the Box
JACK
$312M
| $918K | ﹤0.01% |
13,286
-7,668
| -37% | -$653K |
|
2514
Banco Santander Chile
BSAC
$16.3B
| $917K | ﹤0.01% |
50,018
-10,104
| -17% | -$194K |
|
2515
Magnite
MGNI
$2.76B
| $917K | ﹤0.01% |
121,573
-80,595
| -40% | -$869K |
|
|
TRHC
2516
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $914K | ﹤0.01% |
88,675
-88
| -0.1% | -$835 |
|
2517
State Street SPDR S&P Semiconductor ETF
XSD
$2.72B
| $912K | ﹤0.01% |
4,651
-1,189
| -20% | -$251K |
|
|
RNAM
2518
DELISTED
Avidity Biosciences
RNAM
| $909K | ﹤0.01% |
142,528
-36,204
| -20% | -$312K |
|
2519
RXO
RXO
$3.34B
| $909K | ﹤0.01% |
46,060
-48,307
| -51% | -$951K |
|
|
INBX
2520
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $904K | ﹤0.01% |
49,244
+1,611
| +3% | +$33.7K |
|
2521
Trinity Industries
TRN
$2.49B
| $903K | ﹤0.01% |
37,095
-28,008
| -43% | -$707K |
|
2522
Ashland
ASH
$3.33B
| $901K | ﹤0.01% |
11,027
+3,058
| +38% | +$265K |
|
2523
Kura Oncology
KURA
$800M
| $899K | ﹤0.01% |
98,557
+22,357
| +29% | +$227K |
|
|
VRE
2524
DELISTED
Veris Residential
VRE
| $898K | ﹤0.01% |
54,445
-38,838
| -42% | -$684K |
|
2525
Takeda Pharmaceutical
TAK
$54.6B
| $896K | ﹤0.01% |
57,941
+3,089
| +6% | +$47.8K |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.